VAGINAL VERSUS RECTAL MISOPROSTOL BEFORE LAPAROTOMIC MYOMECTOMY

Main Article Content

ABDELAZIZ I.A.MAHER MD, Bassem Talaat MD

Abstract

Abstract

Background: Leiomyoma is benign, monoclonal tumor of the smooth muscle cells of the myometrium. It is much denser than normal myometrium. It affects mostly women during reproductive age; rarely found before menarche & usually regress after menopause.


Aim: to compare among vaginal & rectal misoprostol-as a preoperative medication-in controlling blood loss throughout myomectomy


Patients and methods: From January 2022 to January 2023, the Zagazig University Hospitals' department of obstetrics and gynecology hosted this randomized controlled experiment.


Results: There was no statistically significant difference in pre-operative mean hemoglobin, 24 hours postoperative hemoglobin content, pulse, need for blood transfusion, diastolic and systolic blood pressure among both groups (p-value>0.05). Regarding peri-operative complications & length of hospital stay in both groups, febrile morbidity and need for additional analgesics were statistically significantly higher in  G2 than G1 (4.5% versus 31.8% and 9.1% versus 40.9% respectively) (p-value=0.04* & 0.01* respectively .However, no statistically significant difference among both groups with regard to hospital stay, need for hysterectomy& other complications as diarrhorea and abdominal cramps (p-value >0.05).

Article Details

How to Cite
Bassem Talaat MD, A. I. M. (2024). VAGINAL VERSUS RECTAL MISOPROSTOL BEFORE LAPAROTOMIC MYOMECTOMY. Obstetrics and Gynaecology Forum, 34(3s), 3120–3125. Retrieved from https://obstetricsandgynaecologyforum.com/index.php/ogf/article/view/926
Section
Articles

Most read articles by the same author(s)

Similar Articles

1 2 3 4 > >> 

You may also start an advanced similarity search for this article.